Department of Physical Medicine and Rehabilitation, Medicine Faculty, University of Pamukkale, 20070, Kinikli-Denizli, Turkey.
Int J Clin Oncol. 2013 Apr;18(2):285-92. doi: 10.1007/s10147-012-0377-9. Epub 2012 Feb 10.
We aimed to determine the frequency of fibromyalgia syndrome (FM) in operated breast cancer patients and to research the relationship between FM and the severity of fatigue and quality of life in these breast cancer patients.
The demographic data of 101 operated breast cancer patients were recorded. The patients who had pain were then classified as having regional pain (RP), widespread pain without FM (WP), and widespread pain with FM (WFM). The FM diagnosis was based on the American College of Rheumatology (ACR) criteria. The severity of fatigue was evaluated with the Brief Fatigue Inventory, the disease impact was evaluated with the Fibromyalgia Impact Questionnaire (FIQ), and the quality of life was evaluated with the European Organization for Research on Treatment of Cancer questionnaire Quality of Life-C30 (EORTC-QoL-C30).
There was no pain in 38 (37.6%) patients, whereas there was pain in 63 (62.4%) patients (N = 42, 41.6% had RP, N = 21, 20.8% had WP). Ten (9.9%) of the entire patient cohort were diagnosed as having FM according to the ACR criteria. There were no differences among the 3 groups in respect to demographic characteristics when patients were classified as RP (N = 42), WP (N = 11), and WFM (N = 10) groups. While there were negative correlations between the FIQ and EORTC-QoL-C30-function score (r = -0.727) and EORTC-QoL-C30-global score (r = -0.488), there was a positive correlation between the FIQ and EORTC-QoL-C30-symptom score (r = 0.726).
We note that the frequency of FM in the operated breast cancer patients in this study was higher than that reported in normal populations in the literature. Also, we found that the presence of FM had negative effects on the quality of life of the breast cancer patients. Accordingly, in the evaluation of widespread pain and complaints of fatigue in long-surviving breast cancer patients, after metastatic disease is excluded, the probability of FM should be kept in mind, so that appropriate treatment can be initiated to improve their functional status and quality of life.
我们旨在确定患有纤维肌痛综合征(FM)的手术乳腺癌患者的频率,并研究 FM 与这些乳腺癌患者的疲劳严重程度和生活质量之间的关系。
记录了 101 名手术乳腺癌患者的人口统计学数据。有疼痛的患者随后被分为区域疼痛(RP)、无 FM 的广泛疼痛(WP)和有 FM 的广泛疼痛(WFM)。FM 的诊断基于美国风湿病学会(ACR)标准。使用简短疲劳量表评估疲劳严重程度,使用纤维肌痛影响问卷(FIQ)评估疾病影响,使用欧洲癌症研究与治疗组织生活质量问卷(EORTC-QoL-C30)评估生活质量。
38 名(37.6%)患者无疼痛,63 名(62.4%)患者有疼痛(N=42,41.6%有 RP,N=21,20.8%有 WP)。根据 ACR 标准,整个患者队列中有 10 名(9.9%)被诊断为患有 FM。当患者分为 RP(N=42)、WP(N=11)和 WFM(N=10)组时,三组在人口统计学特征方面没有差异。FIQ 与 EORTC-QoL-C30 功能评分(r=-0.727)和 EORTC-QoL-C30 总体评分(r=-0.488)呈负相关,而 FIQ 与 EORTC-QoL-C30 症状评分(r=0.726)呈正相关。
我们注意到,本研究中手术乳腺癌患者中 FM 的频率高于文献中正常人群的报道。此外,我们发现 FM 的存在对乳腺癌患者的生活质量有负面影响。因此,在评估广泛疼痛和疲劳主诉时,在排除转移性疾病后,应牢记 FM 的可能性,以便进行适当的治疗,以改善他们的功能状态和生活质量。